CHICAGO – Improved radiotherapy techniques have made it possible for men to achieve reductions in PSA to below detectable levels following radiation treatment for prostate cancer, according to new ...

MONTREAL—Patients with locally advanced prostate cancer (PCa) have significantly better long-term biochemical disease-free survival (bDFS) if they are treated with external beam radiation therapy ...

EBRT with or without STAD showed similar 15-year PCSS and OS rates in IRPC patients, with high PSA failure rates observed. Multivariate analysis indicated greater side effects in the STAD group ...

Long-term results following RP are suboptimal when used as monotherapy for high-risk prostate cancer. There is no accepted multimodal strategy for high-risk disease and recurrence following current ...

What happens if PSA levels start rising after surgery or radiation for prostate cancer? Up to a third of men treated for the disease will eventually confront this problem. If there's no accompanying ...

Regarding disease-free survival, 88.6% of patients in the SBRT group were free from disease progression after three years, compared to 92.1% receiving longer courses of radiation. The difference was ...

The postsurgical combination of androgen deprivation therapy and Erleada has shown promising results in prostate cancer. Postsurgical treatment with androgen deprivation therapy and Erleada ...

Freedom from distant metastasis (FFDM) at 10 years was 93% with adjuvant RT and 90% with salvage treatment. After a median follow-up of 7.8 years, 52 patients in the adjuvant RT arm had died as ...